GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » FCF Margin %

Incannex Healthcare (STU:IQI) FCF Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Incannex Healthcare FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Incannex Healthcare's Free Cash Flow for the three months ended in Mar. 2024 was €-4.00 Mil. Incannex Healthcare's Revenue for the three months ended in Mar. 2024 was €0.00 Mil. Therefore, Incannex Healthcare's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Incannex Healthcare's current FCF Yield % is -13.30%.

The historical rank and industry rank for Incannex Healthcare's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Incannex Healthcare was -185.45%. The lowest was -969.12%. And the median was -364.10%.

STU:IQI's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: -0.03
* Ranked among companies with meaningful FCF Margin % only.


Incannex Healthcare FCF Margin % Historical Data

The historical data trend for Incannex Healthcare's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare FCF Margin % Chart

Incannex Healthcare Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -286.03 -185.48 -646.07 -363.94 -

Incannex Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Incannex Healthcare's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Incannex Healthcare's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Incannex Healthcare's FCF Margin % falls into.



Incannex Healthcare FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Incannex Healthcare's FCF Margin for the fiscal year that ended in Jun. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2022 )/Revenue (A: Jun. 2022 )
=-8.334/0
= %

Incannex Healthcare's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-3.997/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incannex Healthcare FCF Margin % Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Incannex Healthcare (STU:IQI) Business Description

Traded in Other Exchanges
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.